MADISON, Wis. (PRWEB) June 09, 2015 -- Quincy Bioscience, a Wisconsin-based biotech company, announces that Prevagen is the 2015 recipient of the Vity Award for the best brain support formula.
Vity Awards are given each year by Vitamin Retailer magazine, the leading trade publication in the vitamin/supplement industry. Awards are voted on by retailer readers across the country. Prevagen is a four-time Vity Award winner for the best brain support supplement.
“We are thrilled that Prevagen is a four-time Vity Award winner for the best brain support supplement,” said Mark Underwood, president and co-founder of Quincy Bioscience. “We routinely hear from people telling us how Prevagen helps their thinking, concentration, and memory. We thank our retail partners who help communicate the value of Prevagen to their customers who want to keep their memory sharp for many years to come.”
For over seven years, Quincy Bioscience has been promoting the benefits of apoaequorin, the unique ingredient in Prevagen. Apoaequorin is a protein originally discovered in jellyfish which has been proven to support brain cell function. Prevagen has shown to improve cognitive function in the Madison Memory Study, a double-blind, placebo-controlled study of 218 adults over 90 days.
The demand for the brain health products continue to grow as Americans are leading healthier and longer lives than ever before. Backed with published safety and efficacy studies, Prevagen has helped hundreds of thousands of customers through its nationwide distribution in drugstores, health food stores, and physician offices since the product was launched in 2007.
For more information, please visit http://www.prevagen.com.
About Quincy Bioscience:
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, focused on the discovery, development and commercialization of novel technologies to support brain health in aging, with a specific emphasis on memory support and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the patented protein apoaequorin, which has been tested to show improvements in cognition and memory in clinical trials.
Todd Olson, Quincy Bioscience, http://www.quincybioscience.com, 608-827-8134, [email protected]
SOURCE Quincy Bioscience